Passiflora Laboratories Private Limited
About Passiflora Laboratories Private Limited
Data last updated:
Passiflora Laboratories Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the cosmetics and makeup products segment of the FMCG sector. It was incorporated on 10 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24110PN2019PTC184055. Its GSTIN is 27AAKCP5396F1ZY (Maharashtra).
The company has an authorised share capital of ₹12 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Rajesh Popatlal Oswal and Kajal Pravin Jagtap.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Milkat No – 453 Gate No – 389 Shed No 1 Bhare Mulshi, Pune, Maharashtra, India – 412115.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.21 Cr, a growth of 96% compared to the previous year. For the same year it recorded a net profit of ₹13.29 Lakh (net margin 6%) and EBITDA of ₹34.88 Lakh (EBITDA margin 15.8%). Revenue has grown at a compounded annual rate (CAGR) of 46% over three years and 163% over five years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressMilkat No – 453 Gate No – 389 Shed No 1 Bhare Mulshi, Pune, Maharashtra, India – 412115
- IndustryFMCG, Cosmetics & Makeup Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Passiflora Laboratories Private Limited
The main business activity of Passiflora Laboratories is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Passiflora Laboratories Private Limited FY 2025 filings available
Passiflora Laboratories Private Limited reported revenue of ₹2.21 Cr (up 96% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Passiflora Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 163% over five years, including 96% growth in the latest year. EBITDA rose 152% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Passiflora Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹34.88 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13.29 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Passiflora Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Passiflora Laboratories are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Passiflora Laboratories Private Limited
Passiflora Laboratories Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mesha Pharma Private Limited | ₹2.26 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Mumbai, Maharashtra, India |
| Archaic Remedies Private Limited | ₹2.25 Cr (FY 2025) | •••• | •••• | 470.0% | •••• | Pune, Maharashtra, India |
| Sunpreet Packaging Private Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | 1116020100.0% | •••• | Chandigarh, India |
| Asmee Pharma Private Limited | ₹2.23 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Vadodara, Gujarat, India |
| Sikha Mediequip Private Limited | ₹2.22 Cr (FY 2024) | •••• | •••• | -19.0% | •••• | Delhi, India |
| Passiflora Laboratories Private Limited this company | ₹2.21 Cr (FY 2025) | •••• | •••• | 96.0% | •••• | Pune, Maharashtra, India |
| Bini Organics Private Limited | ₹2.18 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Honeychem Pharma Research Private Limited | ₹2.18 Cr (FY 2025) | •••• | •••• | 60.0% | •••• | Bangalore, Karnataka, India |
| Rivalife Care Private Limited | ₹2.17 Cr (FY 2025) | •••• | •••• | 2704.0% | •••• | Mumbai, Maharashtra, India |
| Aapl Closures Private Limited | ₹2.16 Cr (FY 2025) | •••• | •••• | •••• | Bhiwandi, Maharashtra, India | |
| Vidisa Formulations Private Limited | ₹2.14 Cr (FY 2025) | •••• | •••• | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Passiflora Laboratories by revenue in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Passiflora Laboratories Private Limited
Passiflora Laboratories Private Limited is audited by P S ACHALIYA & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P S ACHALIYA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Passiflora Laboratories Private Limited
Passiflora Laboratories has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Popatlal Oswal Also directs: Shubh Medicorp (India) Private Limited | Director | 10 May 2019 | 7 Years 5 Months | Current |
| Kajal Pravin Jagtap | Director | 10 May 2019 | 7 Years 5 Months | Current |
| Kshirsagar Shrikant Vijay Also directs: Chakan Life Sciences Private Limited | Director | 24 Feb 2021 | 5 Years 7 Months | Current |
| Pradyumn Prahlad Singh | Additional Director | 08 Dec 2025 | 0 Years 10 Months | Current |
Ownership and Shareholding of Passiflora Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Passiflora Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Nov 2021 | Others | ₹50 Lakh | Open |
| 09 Nov 2021 | Others | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Passiflora Laboratories Private Limited
Employment history and EPFO contributions of people linked to Passiflora Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Passiflora Laboratories Private Limited
Passiflora Laboratories Private Limited has 8 board changes on record since 2019: 4 appointments and 4 cessations. The latest: Pradyumn Prahlad Singh was appointed as Additional Director on 08 Dec 2025.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Passiflora Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Passiflora Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Passiflora Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Passiflora Laboratories Private Limited
Passiflora Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCP5396F1ZY | Maharashtra | Active | 30 Jul 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Passiflora Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Passiflora Laboratories Private Limited
Passiflora Laboratories is an active private limited company based in Pune, Maharashtra, India. The company works in cosmetics and makeup products, within the FMCG industry. It was incorporated on 10 May 2019 (7+ years old) and is registered under CIN U24110PN2019PTC184055.
Passiflora Laboratories reported revenue of ₹2.21 Cr for FY 2025 (up 96% YoY).
Passiflora Laboratories has 4 current directors:
- Rajesh Popatlal Oswal - Director
- Kajal Pravin Jagtap - Director
- Kshirsagar Shrikant Vijay - Director
- Pradyumn Prahlad Singh - Additional Director
Passiflora Laboratories reported a net profit of ₹13.29 Lakh (net margin 6%) and EBITDA of ₹34.88 Lakh (EBITDA margin 15.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Passiflora Laboratories is 46% over three years and 163% over five years. In the latest year (FY 2025) revenue rose 96%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Passiflora Laboratories is 27AAKCP5396F1ZY, registered in Maharashtra.
The CIN (Corporate Identification Number) of Passiflora Laboratories is U24110PN2019PTC184055. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Passiflora Laboratories was incorporated on 10 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Passiflora Laboratories by revenue are Mesha Pharma Private Limited, Archaic Remedies Private Limited, Sunpreet Packaging Private Limited, Asmee Pharma Private Limited, Sikha Mediequip Private Limited and 5 more, all in the same principal business activity (Manufacture of basic pharmaceutical products and pharmaceutical preparations).
Pradyumn Prahlad Singh was appointed as Additional Director on 08 Dec 2025. Kalpesh Shirish Achaliya ceased to be Additional Director on 30 Sep 2022. Ashish Mohanlal Gundecha ceased to be Additional Director on 30 Nov 2021. Passiflora Laboratories has 8 board changes on record in total.
The registered office of Passiflora Laboratories is at Milkat No – 453 Gate No – 389 Shed No 1 Bhare Mulshi, Pune, Maharashtra, India – 412115.